Prostate Cancer Trial, Recruiting NCT06487507 Sponsor: University of Miami Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06487507
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men between 18 and 80 years old who are already scheduled to have their prostate surgically removed as part of their standard medical care.
  • People with a body mass index (a measure of body weight relative to height) between 18.5 and 40.
  • People who are able to read, write, speak, and understand English and/or Spanish.
  • People who are able to give informed consent (meaning they can understand and agree to what the trial involves).
  • People who are willing to follow the specific dietary plans provided during the study.
  • People whose blood and organ function meet certain minimum levels, as assessed by their treating doctor — this includes acceptable levels of blood cells, liver function, and kidney function (confirm with trial site for exact details).

Who may not be able to join:

  • People who are currently following a Mediterranean, low-carbohydrate, ketogenic, vegan, vegetarian, or high-fibre diet, or who are taking supplements, vitamins, or minerals that could interfere with the diets being tested in the study.
  • People who have previously had problems tolerating high-fibre diets.
  • People who have colitis, irritable bowel syndrome (IBS), or another gut or digestive condition, as determined by their doctor.
  • People who have food allergies or major dietary restrictions.
  • People who are currently receiving medical treatment for Type 1 or Type 2 diabetes.
  • People who have lost or gained 5% or more of their body weight in the last 30 days, whether intentionally or not.
  • People who have previously had any type of weight loss surgery.
  • People with any other medical reasons that the trial investigators determine make participation unsafe (confirm with trial site).
  • People with a history of diabetic ketoacidosis (a serious diabetes-related complication).
  • People with a history of gout.
  • People whose immune system is suppressed — for example, due to an organ transplant or immunosuppressant medication — as determined by their doctor.
  • People who have had their gallbladder removed, or who are planning to have it removed.
  • People who are currently receiving systemic treatment (such as chemotherapy) for another cancer.
  • People who have previously received treatment for prostate cancer.
  • People who have previously had radiation therapy to the pelvic area.
  • People who do not have the capacity to make their own informed decisions about participation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 April 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of patients consuming Mediterranean diet

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov